546 related articles for article (PubMed ID: 2981240)
1. The constant plasma 18-hydroxycorticosterone to aldosterone ratio: an expression of the efficacy of corticosterone methyloxidase type II activity in disorders with variable aldosterone production.
Kater CE; Biglieri EG; Rost CR; Schambelan M; Hirai J; Chang BC; Brust N
J Clin Endocrinol Metab; 1985 Feb; 60(2):225-8. PubMed ID: 2981240
[TBL] [Abstract][Full Text] [Related]
2. Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
Sowers JR; Beck FW; Waters BK; Barrett JD; Welch BG
J Clin Endocrinol Metab; 1985 Jul; 61(1):60-7. PubMed ID: 2987296
[TBL] [Abstract][Full Text] [Related]
3. The natural history of salt-wasting disorders of adrenal and renal origin.
Rösler A
J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251
[TBL] [Abstract][Full Text] [Related]
4. Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumor.
Uchida K; Kigoshi T; Iwasaki R; Morimoto S
Jpn J Med; 1989; 28(4):446-51. PubMed ID: 2554039
[TBL] [Abstract][Full Text] [Related]
5. Corticosterone methyloxidase II activity during hemodialysis.
Zager PG; Spalding CT; Frey HJ; Brittenham MC
J Lab Clin Med; 1987 Feb; 109(2):178-83. PubMed ID: 3543178
[TBL] [Abstract][Full Text] [Related]
6. Multisteroid analysis in children with terminal aldosterone biosynthesis defects.
Peter M; Partsch CJ; Sippell WG
J Clin Endocrinol Metab; 1995 May; 80(5):1622-7. PubMed ID: 7745009
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the mineralocorticoid hormones in adrenocortical disorders with adrenocorticotropin excess.
Kater CE; Biglieri EG; Brust N; Chang B; Hirai J
Clin Exp Hypertens A; 1982; 4(9-10):1749-58. PubMed ID: 6291814
[TBL] [Abstract][Full Text] [Related]
8. Acquired partial corticosterone methyl oxidase type II defect in diabetes mellitus. Case of hyperreninemic hypoaldosteronism.
Braithwaite SS; Barbato AL; Emanuele MA
Diabetes Care; 1990 Jul; 13(7):790-2. PubMed ID: 2167193
[TBL] [Abstract][Full Text] [Related]
9. Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism.
Iwasaki R; Kigoshi T; Uchida K; Morimoto S
Acta Endocrinol (Copenh); 1989 Jul; 121(1):83-9. PubMed ID: 2545066
[TBL] [Abstract][Full Text] [Related]
10. Inborn error in the terminal step of aldosterone biosynthesis. Corticosterone methyl oxidase tpe II deficiency in a North American pedigree.
Veldhuis JD; Kulin HE; Santen RJ; Wilson TE; Melby JC
N Engl J Med; 1980 Jul; 303(3):117-21. PubMed ID: 6991942
[TBL] [Abstract][Full Text] [Related]
11. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia.
Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S
J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181
[TBL] [Abstract][Full Text] [Related]
12. Plasma corticosteroids in hyperreninemic hypoaldosteronism: evidence for diffuse impairment of the zona glomerulosa.
Stern N; Beck FW; Sowers JR; Tuck M; Hsueh WA; Zipser RD
J Clin Endocrinol Metab; 1983 Jul; 57(1):217-20. PubMed ID: 6304133
[TBL] [Abstract][Full Text] [Related]
13. Plasma 18-hydroxycorticosterone during continuous ambulatory peritoneal dialysis.
Zager PG; Frey HJ; Gerdes BG
J Lab Clin Med; 1983 Oct; 102(4):604-12. PubMed ID: 6311927
[TBL] [Abstract][Full Text] [Related]
14. Increased excretion of 18-hydroxycorticosterone in patients with adrenal adenomas and hypertension.
Vecsei P; Abdelhamid S; Haack D; Lichtwald K; Lewicka S; von Mittelstädt G
Clin Exp Hypertens A; 1982; 4(9-10):1759-70. PubMed ID: 6291815
[TBL] [Abstract][Full Text] [Related]
15. Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man.
Sowers JR; Sharp B; McCallum RW
J Clin Endocrinol Metab; 1982 Apr; 54(4):869-71. PubMed ID: 7037817
[TBL] [Abstract][Full Text] [Related]
16. Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas.
Kigoshi T; Imaizumi N; Azukizawa S; Yamamoto I; Hosojima H; Uchida K; Morimoto S
Horm Res; 1984; 19(4):224-31. PubMed ID: 6745843
[TBL] [Abstract][Full Text] [Related]
17. Zona glomerulosa function after life-long suppression in two siblings with the hypertensive virilizing form of congenital adrenal hyperplasia.
Rodríguez Portales JA; Arteaga E; López Moreno JM; Biglieri EG
J Clin Endocrinol Metab; 1988 Feb; 66(2):349-54. PubMed ID: 3276723
[TBL] [Abstract][Full Text] [Related]
18. Unresponsiveness of plasma mineralocorticoids to angiotensin II in diabetic patients with asymptomatic normoreninemic hypoaldosteronism.
Kigoshi T; Morimoto S; Uchida K; Hosojima H; Yamamoto I; Imaizumi N; Azukizawa S
J Lab Clin Med; 1985 Feb; 105(2):195-200. PubMed ID: 2982980
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic modulation of 18-hydroxycorticosterone secretion in man.
Sowers JR; Berg G; Tuck ML; Martin VI; Chandler DW; Mayes DM
J Clin Endocrinol Metab; 1982 Mar; 54(3):523-7. PubMed ID: 7035483
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone and other mineralocorticoids in Bartter's syndrome.
Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
